Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Pediatrics. 2023 May 1;151(5):e2022058846. doi: 10.1542/peds.2022-058846

TABLE 2.

Documented Reasons for Prescribing SSRI at Medication Visit (N = 110)

Explicitly Stated Reason for Starting SSRI at Medication Visit Number of Patients, n (%) Contributing Patient Factors Documented at Medication Visit Number of Patients, n (%)

Clinical change documented 63 (57) Documentation of functional impairment 79 (72)
Started or recommended by DBP or Psychiatry, continued by PCP 22 (20) Documentation of severity 50 (46)
Indication not mentioned 20 (18) Screening tool used (eg, Spence, SCARED, PHQ-9) 29 (26)
Family preference 6 (5) Family history of mental health disorder 21 (19)
Suggest by non-MD therapist 5 (5) Challenges with access to treatments 13 (12)
Unable to access other treatment 1 (1) Family history of medication for anxiety or depression 11 (10)

Total % is greater than 100 because >1 option could be selected. DBP, developmental-behavioral pediatrics; MD, medical doctor.